CRKN — Crown Electrokinetics. Income Statement
0.000.00%
Last trade - 00:00- $2.99m
- -$9.79m
- $19.70m
- 22
- 80
- 14
- 32
Annual income statement for Crown Electrokinetics., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.1 | 0 | 0 | 0.153 | 19.7 |
| Cost of Revenue | |||||
| Gross Profit | -0.52 | 0 | — | -0.733 | -0.714 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 8.19 | 33.6 | 15.1 | 21.8 | 43.8 |
| Operating Profit | -8.09 | -33.6 | -15.1 | -21.7 | -24.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -9.6 | -40.8 | -14.3 | -29 | -25.9 |
| Net Income After Taxes | -9.6 | -40.8 | -14.3 | -29 | -25.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.6 | -40.8 | -14.3 | -29 | -25.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.6 | -40.8 | -14.4 | -29.7 | -32.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1,397,421 | -4,036,639 | -1,111,267 | -110,454 | -548 |
| Dividends per Share |